Pharma Business - June 11, 2026
Camurus receives FDA setback for CAM2029 in US acromegaly review
Camurus has received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application for CAM2029 (Oclaiz), a once-monthly octreotide treatment for patients with acromegaly.
In a new job - June 8, 2026
CellaVision appoints new CEO
CellaVision’s board has appointed Steve Ferguson as the company’s new Chief Executive Officer with immediate effect.
Collaboration - June 8, 2026
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China
Moberg Pharma has entered into a license agreement with Karo Healthcare regarding the commercialization of the nail fungus drug MOB-015 (Terclara) in China through the rapidly growing cross-border e-commerce channel.
Pharma article - June 8, 2026
Ipsen moves Nordic headquarters to Hagastaden
Ipsen is relocating its Nordic headquarters from Kista to Hagastaden, one of Stockholm’s most dynamic life science hubs.
Pharma Business - June 5, 2026
Diamyd Medical provides business update
As part of an ongoing strategic review, the company has received several proposals from external parties, including formal non-binding Letters of Intent, as well as invitations to invest into various business opportunities, it states.
Funding - June 3, 2026
Charlotte Thålin awarded SEK 20 million grant for COPD research
Thålin has been awarded the Swedish Heart-Lung Foundation’s major research grant for her work on antibody-based protection against infections in chronic obstructive pulmonary disease (COPD).
